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AbstrAct
Aging (senescence) includes causal mechanisms (etiologies) of late-life disease, 
which remain poorly understood. According to the recently proposed hyperfunction 
theory, based on the older theory of antagonistic pleiotropy, senescent pathologies 
can arise from futile, post-reproductive run-on of processes that in early life 
promote fitness. Here we apply this idea to investigate the etiology of senescent 
pathologies in the reproductive system of Caenorhabditis elegans hermaphrodites, 
particularly distal gonad degeneration and disintegration. Hermaphrodite germ 
cells frequently undergo “physiological” (non-damage-induced) apoptosis (PA) to 
provision growing oocytes. Run-on of such PA is a potential cause of age-related 
gonad degeneration. We document the continuation of germline apoptosis in later 
life, and report that genetically blocking or increasing PA retards or accelerates 
degeneration, respectively. In wild-type males, which lack germ line apoptosis, gonad 
disintegration does not occur. However, mutational induction of PA in males does not 
lead to gonad disintegration. These results suggest that as germ-cell proliferation rate 
declines markedly in aging hermaphrodites (but not males), run-on of PA becomes 
a pathogenic mechanism that promotes gonad degeneration. This illustrates how 
hyperfunction, or non-adaptive run-on in later life of a process that promotes fitness 
in early life, can promote atrophic senescent pathology in C. elegans.
INtrODUctION
Biogerontologists traditionally use lifespan as a 
measure of aging. However, aging leads to death by 
causing the development of senescent pathologies [1, 
2]. Arguably, discovering the causes (etiologies) of such 
pathologies is key to understanding aging. Senescence 
causes numerous pathologies, and which pathologies 
limit life varies according to species, individual and 
environment. Thus, in a model organism like C. elegans, 
understanding how a given senescent pathology originates 
is of interest, whether it limits lifespan or not. This 
study therefore focuses not on lifespan but on senescent 
pathology.
The biological mechanisms of senescence in C. 
elegans remain poorly understood. One suggested cause 
of aging is stochastic molecular damage, e.g. oxidative 
damage [3, 4]. However, difficulty in demonstrating 
this in C. elegans [5-7] has increased interest in possible 
alternative mechanisms. According to evolutionary 
theory, a major cause of aging is antagonistic pleiotropy; 
specifically, the deleterious effects later in life of wild-
type genes that promote fitness earlier in life [8]. In 
terms of proximate mechanisms, antagonistic pleiotropy 
can manifest e.g. as physiological costs of reproduction 
[9, 10], or as destructive late-life gene action (run-on 
or hyperfunction) [11, 12]. Such run-on, or pathogenic 
continuation in later life of processes that promote 
fitness in early life, has been likened to a faucet left 
on [13, 14], and can lead to lethal senescent pathology 
through overgrowth (hypertrophy or hyperplasia, e.g. 
cardiac hypertrophy or cancer, respectively) or atrophy 
(e.g. osteoporosis). Such antagonistic pleiotropy-related 
mechanisms imply that the development of senescent 
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pathologies can, like development per se, be understood 
as genetically determined phenotypes. Thus, the 
developmental genetics of senescent pathologies may be 
key to understanding aging. 
In C. elegans hermaphrodites, age-related 
pathologies suggestive of hyperfunction affect a number 
of organs [15]. This includes the gonad, which consists of 
two U-shaped gonad arms linked to a single central uterus. 
At the distal end of each gonad is a population of mitotic 
stem cells, some of which undergo meiosis, eventually 
forming sperm and then, subsequently, large oocytes in the 
proximal gonad arm (Figure 1A). Mature oocytes are then 
ovulated into the spermatheca where they are fertilized 
by sperm, and then pass via the uterus and vulva into the 
world beyond. 
During aging, the hermaphrodite gonad undergoes 
a striking morphological transformation (Figure 1A). 
Initially, after depletion of sperm, unfertilized oocytes 
accumulate [16] and enter the uterus, where they become 
hypertrophic, forming large tumors [17-19]. By contrast, 
the aging distal gonad undergoes severe atrophy and 
eventual disintegration [16, 18, 20]. 
In this study, we take a developmental pathology 
approach to investigate C. elegans gonad senescence, 
and present evidence that post-reproductive physiological 
apoptosis (PA) in the germline contributes to distal gonad 
degeneration. 
rEsULts
the aging hermaphrodite germline undergoes 
atrophy and hypertrophy
We first re-examined the pattern of age-related 
pathology in the hermaphrodite gonad using Nomarski 
microscopy. Initially, shrivelling (atrophy) of the distal 
gonad was seen, which was followed by disintegration 
(fragmentation) in most animals by day 12 of adulthood. 
While little remained of the distal germline of such 
animals, atrophy of the proximal germline distal to the 
spermatheca often left one or more enlarged oocytes 
within the gonadal sheath.
To quantify germline degeneration, we used an 
approach based on an earlier study [20], defining 5 stages 
of gonad aging. At stage 1 the gonad was full sized and 
youthful in appearance; at stage 2 it was still intact, 
but showed slight signs of atrophy and deterioration; at 
stage 3 it showed clear atrophy and signs of impending 
disintegration (i.e. marked narrowing at one or more 
points along the gonad); and at stage 4, fragmentation had 
occurred (Figure 1B). At stage 5, which was occasionally 
seen, overall decrepitude was too severe to discern distal 
gonad fragments. Scoring germline disintegration on day 
1, 8 and 12 of adulthood (20˚C), and comparing these, 
confirmed that there is an age-related increase in gonad 
deterioration (Figure 1C). By day 8 more than a third of 
animals showed disintegrated gonads, rising to 80% by 
day 12. 
Gonad degeneration was accompanied by a 
progressive reduction in germ cell number. Between 
day 4 and day 8, the number of germ cells decreased 
markedly (Figure 1D, 1E, measured by DAPI staining). 
Thus, between the end of reproduction (around day 4) 
and day 12 of adulthood, the aging germline undergoes 
severe atrophy in the main, syncytial component, and 
hypertrophy of cellularized oocytes (Figure 1A).
continued physiological apoptosis in the aging 
hermaphrodite germline
We then considered the causes of these age-related 
pathologies. Uterine tumor formation appears to result 
from run-on of growth in unfertilized oocytes [16-19]. We 
explored the possibility that distal gonad disintegration 
also results from run-on of functions that promote early 
life fitness.
In the distal arm, meiotic cells line the gonad as a 
syncytium and are connected to a central core of cytoplasm 
(or rachis). Production of cytoplasm by germ cells, and 
germ cell apoptosis, generates a distal to proximal flow of 
cytoplasm which provisions expanding oocytes near the 
bend in the gonad [21]. Such “physiological” apoptosis 
(PA), which is distinct from stress-induced apoptosis 
(e.g. it is independent of p53 [cep-1]), is a major cause of 
germline cell loss in early adulthood: at least 50% [22] and 
as many as 97% [23] of germline cells undergo PA. By 
provisioning developing oocytes, in a fashion analogous 
to nurse cells in mammals, PA contributes to reproductive 
fitness [24]. One possibility is that PA is not switched off 
in later life and that apoptotic run-on promotes atrophy. 
Plausibly, maintenance of the distal gonad reflects a 
balance between the rate of germ-cell proliferation and 
of PA. The number of mitotic germ cells does decline 
with age in hermaphrodites [18], which may contribute 
to senescent gonad atrophy. Here we explore the 
possibility that in the context of declining rate of germ-cell 
proliferation, run-on of PA promotes gonad degeneration. 
To test for the presence of such post-reproductive 
PA, we scored age changes in levels of apoptosis, using 
CED-1::GFP which is visible in somatic sheath cells that 
surround each apoptotic corpse [25]. This showed that 
apoptotic corpses are abundant until at least day 8 of 
adulthood (Figure 2A, 2B). Normalization to the number 
of germ cell nuclei revealed an increase in apoptotic 
corpse frequency from day 1 to day 4, followed by a 
modest decrease by day 8 (Figure 2C, 2D), consistent with 
previous observations [18]. We also scored age changes in 
cells taking up the vital dye SYTO 12, which confirmed 
the presence of apoptotic corpses up to at least day 8 
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Figure 1: Aging pathology in the C. elegans hermaphrodite gonad A. Schematic summary of major age changes in the anatomy of 
the hermaphrodite gonad, derived from previous sources [16, 18-20, 62, 63] and this study. Top, young, reproductive adult. Middle, post-
reproductive adult, shortly after sperm depletion; note stacking of oocytes in proximal gonad and presence of oocytes in the uterus. Bottom, 
terminal state after pathogenetic changes in the aging gonad. Fragments comprised of clumps of cellularized germ cells are all that remains 
of the distal gonad, the terminal oocyte has undergone hypertrophy, and oocytes within the uterus have developed into a large tumor. b. 
Stages 1 - 4 of gonad deterioration; images from Nomarski microscopy. Class 3 arrowhead, narrowing of distal gonad. Class 4 arrowheads, 
distal gonad fragments. Scale bar, 20 µm. c. Age increase in gonad degeneration (wild type hermaphrodite). Each dot represents an 
individual animal. *** p < 0.001, Wilcoxon-Mann Whitney test. D., E. Numbers of germline nuclei decline with age. D. Gonads of young 
and old hermaphrodites stained with DNA-staining fluorescent dye (DAPI); scale bar, 20 µm. Note smaller number of nuclei in 8 day old 
worm. T, DNA mass in uterine tumor. PG, proximal gonad, DG, distal gonad. E. Age change in number of germline nuclei (stage 4, 5 
worms on day 8 not included); * 0.01 < p < 0.05, *** p < 0.001, Student’s t test, compared to day 1; error bars, S.E.M.; n.s., not statistically 
significant. N, sample size.
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Figure 2: Post-reproductive run-on of germline apoptosis. A. Presence of apoptotic cell corpses in later life. Apoptotic (CED-
1::GFP positive) cells (arrowheads) in the germline of old hermaphrodite (day 8 of adulthood). b. Age changes in mean number of apoptotic 
cells/gonad arm. c. Overlaid images of DAPI-stained nuclei and CED-1::GFP positive apoptotic cells in post-reproductive hermaphrodite 
gonad. D. Number of apoptotic corpses normalized to nuclear number. E. Genetic pathways regulating cell death in C. elegans (simplified 
scheme). F., G. ced-3(n717) suppresses gonad degeneration. In F. the wild-type (WT) worm exhibits gonad class 4 and the ced-3 mutant 
gonad class 2; note in the latter that the gonad syncytium occupies much of the proximal gonad. A., c., F. Scale bar, 20 µm. D.G., distal 
gonad, P.G., proximal gonad. Error bars, S.E.M.; n.s., not statistically significant; * 0.01 < p < 0.05, ** 0.001 < p < 0.01, *** p < 0.001, 
Student’s t test, compared to day 1 b., D., Wilcoxon-Mann Whitney test compared to wild type G.. N, sample size.
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(Supplementary Figure 1). These results imply that worms 
do not switch off PA after the cessation of reproduction, 
and suggest the presence of an apoptotic open faucet (i.e. 
run-on of PA) in the aging germline. 
Altered gonad degeneration rate in germline 
apoptosis mutants
To probe whether continued, post-reproductive 
apoptosis promotes hermaphrodite gonad degeneration, 
we blocked apoptosis using the mutation ced-3(n717) 
(cell death defective), which abrogates function of the 
executioner caspase CED-3 and blocks both somatic and 
germline apoptosis [22] (Figure 2E). This caused a marked 
inhibition (deceleration) of gonadal degeneration, though 
degeneration still did eventually occur (Figure 2F and 
2G). Three other ced-3 mutant alleles, n1286, n2454 and 
n2885, like n717, similarly suppressed germline apoptosis 
(Figure 3A) and slowed gonad degeneration (Figure 3B-
3D). ced-4(n1162) (Apaf-1-like protein), another mutation 
that inhibits somatic and germline apoptosis [22] also 
inhibited gonad degeneration (Figure 3E). 
To exclude the possibility that this inhibition 
of gonad degeneration is caused by loss of somatic 
apoptosis, we tested the gain-of-function mutation ced-
9(n1950) (BCL-2-like protein), which suppresses somatic 
apoptosis, but not physiological apoptosis in the germline 
[22] (Figure 2E). ced-9(n1950) did not suppress gonad 
degeneration (Figure 3F). Moreover, RNAi inhibition 
of ced-3 function from day 4 of adulthood onwards was 
sufficient to inhibit gonad degeneration (Figure 3G). 
Taken together these results support the hypothesis 
that germline apoptosis in later life promotes gonad 
atrophy. However, a caveat here is that as ced-3 and ced-4 
mutants age, the distal gonad syncytium expands around 
the bend of the gonad arm, eventually filling most of the 
gonad distal to the spermatheca [22] (Figure 2F). Thus a 
formal possibility is that a mechanism other than run-on 
of PA causes distal gonad atrophy, and that atrophy can be 
suppressed by germline hypertrophy caused by blocking 
PA. 
To exclude this we took a different approach to 
test the PA open faucet hypothesis further, and asked 
whether increasing the level of germline apoptosis would 
increase the rate of gonad degeneration. Mutations in 
gld-1 (defective in germ line development) can have a 
variety of phenotypic effects, including formation of 
germline tumours and abolition of oogenesis [26]. gld-
1(op236) is an unusual allele that increases sensitivity 
to damage-induced germline apoptosis, and causes a 
temperature-sensitive increase in PA; it also causes an 
extension in the pachytene region which reduces the 
number of oocytes in the proximal gonad arm [27]. At 
25˚C gld-1(op236) increased gonad degeneration rate 
(Figure 4A). We also tested three other mutants that 
increase frequency of germline apoptosis, lip-1(zh15), lip-
1(gt448) (lip-1 = lateral-signal-induced phosphatase 1) 
and ced-9(n1653) (25˚C) [22, 27, 28]. Again, all increased 
gonad degeneration rate (Figure 4B). These results suggest 
that post-reproductive germline apoptosis is sufficient to 
promote gonad degeneration. 
We examined in more detail the effects of gld-
1(op236), first confirming that it increases PA levels 
(Supplementary Figure 2B). To verify that acceleration 
of gonad disintegration by gld-1(op236) is caused by 
increased germline apoptosis, we examined a gld-
1(op236); ced-3(n717) double mutant. This showed 
significantly reduced gonad disintegration relative to 
gld-1 alone (Supplementary Figure 2A), although gld-
1 still slightly increased gonad degeneration in ced-3 
worms (p < 0.05). The increase in apoptosis rate in gld-
1(op236) mutants is partially dependent upon CEP-1 
(p53-like protein) [27]. We confirmed this dependency 
(Supplementary Figure 2B), but also found that effects of 
gld-1 on gonad degeneration were not cep-1 dependent 
(Supplementary Figure 2C). These results suggest that 
acceleration of gonad degeneration by gld-1(op236) is 
partially but not wholly attributable to increased PA, and 
that PA-dependent but not cep-1-dependent apoptosis 
promotes gonad degeneration. 
Two forms of apoptosis can occur in the germline: 
physiological apoptosis (PA) and stress-induced apoptosis 
(SIA). Our working model is that post-reproductive 
PA, perhaps occurring due to run-on, causes gonad 
degeneration, but it remains possible that SIA plays a role. 
One possibility is that stress during normal aging induces 
SIA which promotes gonad disintegration. SIA can be 
induced by DNA damage via induction of EGL-1, CED-
13 and CEP-1/p53, or by oxidative, osmotic or thermal 
stress via the MAPK kinases MEK-1 and SEK-1, and 
the p53 antagonist ABL-1 [29] (Figure 2E). If PA causes 
gonad degeneration, then neither cep-1(RNAi) nor the abl-
1(ok171) mutant should suppress gonad degeneration, and 
this proved to be the case (Supplementary Figure 3A, 3B). 
We also disabled both mechanisms of SIA by subjecting 
abl-1(ok171) mutants to cep-1(RNAi) but still saw no 
alteration in rate of gonad degeneration (Supplementary 
Figure 3C). This argues against the idea that germline 
apoptosis in late life is promoted by aging-related stress. 
Taken together these results are consistent with 
the view that continued PA in the germline contributes 
to age-related gonad degeneration. However, blocking 
PA delays gonad degeneration rather than blocking it 
entirely (Figure 2G, Figure 3), indicating the presence 
of additional pathogenetic mechanisms. A plausible 
additional mechanism is declining germ-cell proliferation 
rate.
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Figure 3: suppression of gonad degeneration in apoptosis-defective mutants. A. For all four ced-3 alleles studied here it was 
confirmed using SYTO 12 staining that physiological germline apoptosis is suppressed. b.-D. ced-3 suppresses gonad degeneration. b. 
ced-3(n1286). c. ced-3(n2454). D. ced-3(n2885). E. ced-4(n1162). There is no statistically significant difference between the magnitude 
of the effect of any of the five ced mutations on gonad disintegration on day 8 or 12, except between ced-3(n717) and ced-3(n2454) on day 
12 (p = 0.04). F. ced-9(n1950) has no effect on gonad degeneration rate. G. N2 with ced-3 RNAi from day 4 of adulthood onwards. * 0.01 
< p < 0.05, *** p < 0.001, compared to wild type (Wilcoxon-Mann Whitney test); n.s., not statistically significant; error bars, S.E.M.; N, 
sample size.
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Gonad disintegration does not occur in males
In males germline apoptosis does not occur [22]. If 
post-reproductive PA contributes to gonad degeneration, 
then one would expect less germline degeneration 
in males. This proved to be the case. Only a slight 
deterioration in gonad appearance was observed in 
elderly males, and gonad disintegration was never seen 
(Figure 4C, 4D). Moreover, the minor signs of aging in 
the male gonad appeared unaffected by ced-3(n717) 
(Supplementary Figure 4).
To test whether the absence of gonad degeneration 
in males is wholly attributable to the absence of germline 
PA, we examined fog-1(q253) and gld-1(q126) mutant 
males, which are somatically male but exhibit germline 
apoptosis due to germline feminization [22, 26, 30]. 
However, age-related gonad disintegration was not seen 
in either mutant (Supplementary Figure 5). 
These results identify a major sex difference in 
aging pathology in C. elegans: hermaphrodite-specific 
disintegration of the gonad. That switching on PA in 
the male germline is not sufficient to induce gonad 
disintegration could argue against a role for PA in gonad 
atrophy. Alternatively, this finding could instead reflect 
the importance of a balance between rates of germ-cell 
proliferation and PA in maintenance of gonad biomass, 
and relatively high germ-cell proliferation rates in older 
males. According to this model, run-on of PA only causes 
atrophy in the context of declining germ-cell proliferation 
rate. 
Life-extending effects of ced-3 abrogation not 
detected
Does gonad pathology promote late-life mortality? 
Several studies suggest not: for example, lifespan was not 
extended either by blocking uterine tumor growth [19] or 
blocking apoptosis using ced-3(n1286) [20]. However, 
several studies have reported increases in lifespan 
resulting from loss of ced-3 function, either using ced-
3(n717) [31], like ced-3(n1286) a strong allele [32], or 
ced-3 RNAi initiated at L4 [33], which suppresses only 
germline apoptosis. We tested both interventions, but no 
increase in lifespan was seen (Supplementary Figure 6A, 
6B, Supplementary Table 1). This discrepancy could imply 
that effects of ced-3 (and perhaps gonad disintegration) on 
age-related mortality vary according to minor differences 
in culture conditions. To aid future researchers who might 
wish to understand this discrepancy we have provided 
raw mortality data for these trials (Supplementary Dataset 
1, 2). We conclude that neither apoptosis nor gonad 
disintegration contribute to mortality, at least under 
standard conditions as used in this laboratory.
daf-2 can reduce gonad disintegration 
independently of germline apoptosis
Mutation of the daf-2 insulin/IGF-1 receptor 
increases C. elegans lifespan [34] and delays reproductive 
senescence [35, 36] and gonad degeneration [20, 
37]. One possibility is that daf-2(-) suppresses gonad 
degeneration by reducing PA. daf-2 mutants fall broadly 
into two classes: class 1, e.g. daf-2(m577), which are 
less pleiotropic, and class 2, e.g. daf-2(e1370), which are 
more pleiotropic [38]. We found that levels of PA were 
unaffected by daf-2(m577) but reduced by daf-2(e1370) 
(Supplementary Figure 7A, 7B). The observed effect of 
daf-2(e1370) is consistent with a previous study [39], 
though another report described increased germline 
apoptosis in daf-2(e1370) mutants [40]. Other pathways 
have also been shown to influence C. elegans reproductive 
aging, particularly TGF-β Sma/Mab signalling [18, 41, 
42].
To see whether mutation of daf-2 can suppress 
gonad disintegration in the absence of any apparent 
reduction in PA, we examined daf-2(m577) mutants 
(25˚C), and saw a deceleration of gonad disintegration 
(Supplementary Figure 7C). These results imply that daf-
2 mutant suppression of gonad disintegration involves a 
mechanism unrelated to PA, though reduction in PA could 
play a role in class 2 mutants such as daf-2(e1370). One 
possibility is that this mechanism is related to the smaller 
age decrease in mitotic germ cell populations seen in daf-2 
mutants [18, 37].
Extension of lifespan in daf-2 mutants is dependent 
on the daf-16 FoxO transcription factor [34]. It was 
reported that ced-3 mutants are resistant to several 
stressors, and that this stress resistance is daf-16 dependent 
[31, 43]. This raises the possibility that suppression 
of gonad disintegration by ced-3(-) is due to DAF-16 
activation rather than prevention of PA. We therefore 
tested whether suppression of gonad disintegration by ced-
3 was daf-16 dependent, by subjecting daf-16(mgDf50) 
null mutants to ced-3 RNAi. Although daf-16(0) did not 
appear to restore gonad disintegration, the analysis was 
complicated by morphological abnormalities in treated 
worms, including new degenerative changes, characterized 
by numerous large vacuoles, perhaps reflecting necrosis 
(Supplementary Figure 8). 
Hypertrophy of terminal oocytes during aging
Next, we characterized further the enlarged terminal 
oocytes seen in older worms. The terminal oocyte is 
the most proximal non-ovulated oocyte, closest to the 
spermatheca. In many worms a single enlarged oocyte 
was seen, often with several smaller oocytes on its distal 
side, all within the somatic gonadal sheath. In contrast to 
the decrepit tissues that surround them, such hypertrophic 
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Figure 4: Germline apoptosis promotes gonad degeneration. A. gld-1(op236) causes accelerated gonad degeneration. b. lip-
1(zh15), lip-1(gt448) and ced-9(n1653) cause accelerated gonad degeneration. Increased germline apoptosis is a temperature-sensitive 
phenotype, therefore trials were performed at 25˚C, and effects on gonad degeneration scored on day 6 rather than day 8. c., D. Comparison 
of hermaphrodite and male gonads in young and old adults. Scale bar, 20 µm; DG, distal gonad, PG, proximal gonad. n.s., not statistically 
significant; ** 0.001 < p < 0.01, *** p < 0.001, Wilcoxon-Mann Whitney test compared to wild type hermaphrodites.
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Figure 5: Appearance of hypertrophic terminal oocytes in aging C. elegans. A. Normal terminal oocyte in young adult and 
hypertrophic un-ovulated oocyte in old adult. Scale bar, 20 µm; DG, distal gonad, PG, proximal gonad. b. Age change in size of oocytes; 
error bars, S.E.M.. c. Age change in proportion of hypertrophic oocytes. Red line shows hypertrophy threshold. D. Effect of FUdR (25 
µM) from day 1 on proportion of hypertrophic oocytes on day 8 of adulthood. E. Effect of FUdR (25 µM) from day 1 on proportion of 
hypertrophic nuclei on day 8 of adulthood. N, sample size.
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Figure 6: role of hyperfunction in the generation of reproductive pathologies in C. elegans. A. Faucet and sink model for 
the relationship between germ-cell proliferation (GP) and germline physiological apoptosis (PA) in the etiology of hermaphrodite gonad 
degeneration. Left: rate of GP and PA are equal, thereby maintaining gonad biomass. Center: A major decline in GP but not PA. Right: This 
leads to emptying of the sink (i.e. gonad atrophy). Possible scenarios whereby senescent gonad is prevented: in males, there is no PA, and 
GP rate is maintained; in daf-2 mutants, GP rate is maintained. b. Role of open faucets in the origins of multiple senescent pathologies in 
the C. elegans hermaphrodite. Here several forms of run-on are operative. Apoptotic run-on promotes gonad disintegration (atrophy), while 
endomitotic run-on in unfertilized oocytes causes terminal oocyte hypertrophy and uterine tumors. Similarly, post-reproductive run-on of 
vitellogenesis by the intestine leads to yolk accumulation in the body cavity and elsewhere.
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oocytes have a distinctly healthy, youthful appearance 
(Figure 5A). They also exhibit marked twitching 
movements, caused by spasmodic contractions of the 
gonadal sheath (Supplementary Videos 1, 2).
Measurement of terminal oocyte size (cross-
sectional area) during aging revealed both an increase 
in maximum size (+30% on days 8 and 12 compared 
to day 1) and a decrease in minimum size, while mean 
size did not change (Figure 5B); thus, there is an age 
increase in terminal oocyte size variation. Defining 
oocyte hypertrophy as more than 1 standard deviation 
(S.D.) above the day 1 mean size (cross-sectional area 
> 945µm2), on days 1, 8 and 12, 6%, 27% and 33% of 
worms, respectively, contained hypertrophic un-ovulated 
oocytes (Figure 5C).
One possible cause of hypertrophy in terminal 
oocytes is endomitosis which, as previously noted, occurs 
in oocytes in post-reproductive hermaphrodites [44], and 
also in mutants defective in fertilization [45] or ovulation 
(Emo) [46]. Although oocyte hypertrophy was not noted 
in these prior studies, endomitosis could contribute to 
hypertrophy in later life, by mechanisms similar to those 
by which increased ploidy in hypodermal nuclei promote 
worm growth [47]. Consistent with this, we observed an 
increase in frequency of hypertrophic nuclei ( > [mean size 
of day 1 nuclei] + 1 S.D., or > 27.2 µm2) in aging terminal 
oocytes (Figure 5E). Moreover, treatment from day 1 of 
adulthood with 5-fluoro-2’-deoxyuridine (FUdR, 25 µM), 
an inhibitor of DNA replication, markedly reduced the 
number of both hypertrophic oocytes (Figure 5D) and 
hypertrophic nuclei (Figure 5E). This is consistent with 
promotion by endomitotic run-on of hypertrophy in un-
ovulated oocytes.
DIscUssION
These results support the hypothesis that run-
on of reproductive processes contribute to age-related 
pathogenesis in the C. elegans hermaphrodite gonad. We 
present evidence that post-reproductive physiological 
apoptosis promotes germline atrophy (Figure 6B), and 
also that run-on of endomitosis promotes hypertrophy in 
un-ovulated oocytes. The latter is consistent with previous 
evidence that endomitosis contributes to development 
of tumors from unfertilized oocytes in the uterus [19]. 
Moreover, post-reproductive hermaphrodites accumulate 
large quantities of yolk in the body cavity, as the result of 
run-on of intestinal yolk synthesis [48, 49] (Figure 6B). 
Post-reproductive physiological apoptosis and 
aging
Several observations support the view that post-
reproductive physiological apoptosis in the germline 
promotes gonad disintegration: blocking germline but 
not somatic apoptosis delays degeneration; increasing 
germline apoptosis accelerates degeneration. This is 
reminiscent of the action of germline apoptosis as a 
driver of gonad atrophy during starvation-induced adult 
reproductive diapause in C. elegans [50], and also of 
follicular atresia in the loss of oocytes from the human 
ovary [51]. More broadly, these findings provide further 
illustration of how apoptosis can contribute to senescence, 
as recently reviewed [52].
In males, where PA does not occur, gonad 
disintegration does not occur either. However, inducing 
PA in the male gonad did not cause senescent atrophy 
(Supplementary Figure 5), suggesting that absence of 
major atrophy in wild-type males is not simply attributable 
to absence of PA. Instead, these findings support the view 
that run-on of PA leads to gonad degeneration only in the 
context of a decline in the germ-cell proliferation (GP) 
rate relative to that of PA (Figure 6A); the lack of atrophy 
in the male gonad suggests that male GP rate declines less 
with age than in hermaphrodites. By this view, declining 
GP and run-on of PA are primary and secondary causes of 
gonad degeneration. In daf-2 mutants age-related loss of 
germline progenitor cells is reduced in daf-2 mutants [18, 
37]; thus, maintenance of GP production in later life could 
protect against gonad atrophy. The role of declining GP 
rate in gonadal senescence warrants further investigation. 
Our attempts to measure GP rate using 5-ethynyl-2’-
deoxyuridine (EdU) labeling [53] were, unfortunately 
unsuccessful. 
run-on rather than molecular damage as a 
possible cause of aging
These findings provide evidence that late life run-on 
of processes that promote fitness earlier in life contributes 
to senescent pathology in C. elegans. Thus, in at least 
some cases mechanisms promoting senescent pathology 
are distinct from molecular damage accumulation. In 
limited tests that we performed (Supporting Information, 
S9), no evidence of a role of molecular damage in the 
origins of the pathologies under scrutiny was detected. 
This is consistent with previous studies that have argued 
against the importance of reactive oxygen species in 
aging of C. elegans [54-56] and other organisms [6, 12]. 
However, a role for molecular damage in age-related 
pathology in the gonad cannot be ruled out. Consistent 
with the latter possibility, mutation of ced-3 increases 
resistance to several stressors, particularly ER stress [31]. 
Also, molecular damage could contribute to age decline 
in GP rate.
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Understanding aging through senescent pathology 
rather than lifespan
Biogerontological studies of C. elegans usually 
use lifespan as a readout of aging. In this study we have 
instead focused on age-related pathology. The balance 
of evidence suggests that gonadal pathology (distal 
gonad involution, uterine tumors) have, at most, only a 
minor effect on lifespan. However, this does not mean 
that these pathologies are uninformative with respect to 
aging. Aging (senescence) manifests as set of pathologies, 
largely of endogenously origin, that increase in later life 
[1]. The key to understanding the biology of aging is to 
discover the proximate causes of age-related pathologies. 
Whether a particular pathology contributes to mortality 
will depend on context (species, culture conditions, the 
presence of other, more lethal pathologies). For example, 
aging promotes growth of tumors, which kill humans but 
not C. elegans [19]. Thus, studying gonad aging can define 
principles of age-related pathogenesis that lie at the heart 
of the aging process. In the present instance, we mainly 
focus on one likely driver of aging pathology in the gonad: 
post-reproductive physiological apoptosis in the germline, 
which is an example of hyperfunction [12].
MAtErIALs AND MEtHODs
culture conditions and strains
Maintenance of C. elegans strains was performed 
as previously described [57, 58]. Unless otherwise stated, 
worms were maintained at 20˚C on NGM plates seeded 
with E. coli OP50. For experiments using male worms, 
L4 males were picked and maintained at low population 
density (5 worms per plate) to reduce life-shortening 
effects of culturing males in single-sex groups [59]. Strains 
used include N2 (wild type), AH102 lip-1(zh15) IV, 
AV106 spo-11(ok79) IV/nT1 [unc-?(n754) let-?] (IV;V), 
DR1563 daf-2(e1370) III, DR1567 daf-2(m577) III, 
GA184 sod-2(gk257) I, GA1801 lip-1(gt448) IV, GA1802 
ced-9(n1653ts) III, GA1803 gld-1(op236) I; ced-3(n717) 
IV, GR1307 daf-16(mgDf50) I, JK560 fog-1(q253) I, 
JK4563 gld-1(q126sd) I/hT2 [bli-4(e937) let-?(q782) 
qIs48] (I;III), MD701 bcIs39 [(lim-7) ced-1p::GFP + lin-
15(+)] V, MT1522 ced-3(n717) IV, MT2547 ced-4(n1162) 
III, MT3002 ced-3(n1286) IV, MT3970 mab-5(mu14) 
ced-9(n1653) III, MT4770 ced-9(n1950) III, MT8313 
ced-3(n2885) IV, MT8354 ced-3(n2454) IV, TG34 gld-
1(op236) I, and XR1 abl-1(ok171) X. 
fog-1(q253) and gld-1(q126) males with feminized 
germlines were prepared by mating JK560 or JK4563 
hermaphrodites with N2 males, then mating F1 males 
with JK560 or JK4563 hermaphrodites. From among the 
progeny, males were picked, and Fog males (homozygous 
for fog-1(q253) or gld-1(q126)) identified by the presence 
of oocytes in the gonad. fog-1 males were aged at 25˚C 
and gld-1 males at 20˚C. 
Microscopy
Worms were viewed on 2% agarose pads, using 
0.2% levamisole as an anesthetic [60], typically at 400x 
magnification. Differential interference contrast (DIC) 
microscopy was performed using a Zeiss Axioskop2plus 
microscope connected to a Hamamatsu C10600 - Orca 
ER digital camera. The Volocity 5.2 (Improvision, Perkin 
Elmer) software was used for image acquisition and 
quantification. 
Germ cell quantification and apoptotic cell corpse 
assays
To quantify germ cell number worms were stained 
using 6’-diamino-2-phenylindole hydrochloride (DAPI) 
[50]. The number of apoptotic corpses in germlines was 
estimated using the vital dye SYTO 12 [22], or using 
CED-1::GFP [25]. 
To quantify germ cell number worms were stained 
using 6’-diamino-2-phenylidole hydrochloride (DAPI) as 
previously described [50]. Worms were fixed in ice-cold 
methanol for 5 min, washed with M9, and incubated in 
500 ng/ml DAPI solution in the dark for 30 min. Worms 
were then washed once more with M9 and mounted on 
slides for imaging. DAPI-stained worms were imaged at 
200x to obtain an image of the entire visible gonad arm. 
The open source Image J software (NIH image) with the 
ITCN plug-in was used to quantify the number of germ 
cells per gonad arm. 
The number of apoptotic corpses in live worms 
was estimated using the vital dye SYTO 12 (Molecular 
Probes), as previously described [22]. Worms were 
incubated in the dark in 33 µM SYTO 12 for 4 hrs. Worms 
were then transferred to a freshly seeded OP50 plate for an 
hour for the stain to be expelled from the gut. Worms were 
placed on slides and SYTO 12-positive cells, viewed at 
200x magnification, were counted manually. Alternatively, 
worms containing CED-1::GFP which is expressed in the 
gonad sheath was also used to count engulfed apoptotic 
cells [25]. 
Gonad disintegration measurements
Gonad pathology was scored using an approach 
based on that previously described [20]. Gonad health 
status was categorized into five classes. Class 1: gonad 
full-sized and youthful in appearance. Class 2: gonad 
showing slight signs of atrophy and deterioration. Class 
3: gonad showing clear reduction in diameter, and signs 
of impending fragmentation. Class 4: fragmented gonads. 
Class 5: gonad remnants barely recognisable or not 
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discernible; this usually applied to non-motile, elderly 
worms that were close to death. DIC images of one gonad 
arm per worm were obtained, and given a score of 1-5 
by three scorers who had no knowledge of the age or 
genotype of the worms. The rounded mean value of these 
three scores was assigned to each image.
To ensure an unbiased assessment of images of 
aging gonads, blind scoring was performed. To this end, 
all images were renamed and placed in random order 
(shuffled) before scoring. For such shuffling it was 
important both that the filename gave no clue about the 
origin of the file, and that the original image filename 
could be accurately restored after scoring (unshuffled). 
Such shuffling and unshuffling can be achieved manually, 
but to remove potential human error and speed things 
up, we developed a Python script that automates image 
shuffling and unshuffling. This script scans a folder for 
the images it contains and renames the images randomly 
to numbers 0 to [N-1], where N is the number of images in 
the folder. The script automatically creates a ‘key.csv’ file 
which lists the filenames of the shuffled images together 
with their original filenames. This file is then used by 
the inverse function of the script to restore the original 
filenames after the scoring has taken place. 
Without further assistance the user could conduct 
blind scoring on the images, but they still would have to 
revert the scoring by hand by using the ‘key.csv’ file. We 
therefore automated this process as well, by generating an 
Excel spreadsheet during the shuffle phase with the first 
row listing the anonymized filename. In the subsequent 
rows the investigator can fill in any scoring/assessment 
results for each of these images. Using the ‘key.csv’ 
file the script will then also automatically unshuffle this 
spreadsheet, substituting the anonymized filenames with 
the original ones. 
The software can run on Windows (PC), OSX, 
and Linux and is available as a zip file as Supplemental 
Resource 1 (image-shuffle-master). It is also available at 
https://github.com/groakat/image-shuffle.
rNAi treatment
The RNAi clones ced-3 and cep-1 were obtained 
from the Ahringer library, and identity of their inserts 
confirmed by sequencing. RNAi by feeding was 
performed as previously described [61]. Unless otherwise 
stated, worms were raised on E. coli HT115 containing 
the empty vector L4440 (control RNAi) until the L4 stage 
and then transferred to plates seeded with the RNAi clone 
of interest.
survival analysis
Lifespan measurement trials were conducted much 
as previously described [38]. Briefly, worms were raised 
to L4 on control RNAi (20˚C), and then transferred to 
plates seeded with ced-3 RNAi or control RNAi (L4440 
vector control). Worms were transferred to fresh plates 
daily during the reproductive period. Deaths were scored 
and worms that died from desiccation, rupture or bagging 
were censored. 
statistical comparisons
The non-parametric Wilcoxon-Mann Whitney test 
was used in experiments measuring gonad ageing. Data 
obtained as a mean value for a group was analysed using 
the pair-wise Student’s t test. The Tukey Kramer test was 
used to adjust for multiple comparisons. Lifespan datasets 
were compared using the non-parametric log rank test, 
using JMP software (SAS Institute). 
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